Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
09:00-09:15 | 09:00-09:15 |
Advances in Antithrombotic Therapy: Insights from the ESC Guidelines on Management of Non-ST Elevation ACS |
Yaling Han | General Hospital of Northern Theater Command |
09:15-09:22 | 09:15-09:22 |
Discussion |
||
09:22-09:37 | 09:22-09:37 |
Interpretation of Chinese Expert Consensus on Antithrombotic Management of Patients with Atrial Fibrillation and Coronary Artery Disease |
Peng Qu | The Second Affiliated Hospital of Dalian Medical University |
09:37-09:44 | 09:37-09:44 |
Discussion |
||
09:44-09:59 | 09:44-09:59 |
Antithrombotic Therapy in CAD Patients with COVID-19 |
Hesong Zeng | Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology |
09:59-10:06 | 09:59-10:06 |
Discussion |
||
10:06-10:21 | 10:06-10:21 |
How to Reduce the Risk of Stent Thrombosis in Patients Treated with Bio-Resorbable Stent: Insights from the Chinese Expert Consensus on the Clinical Application of Coronary Bioresorbable Scaffold |
Yaojun Zhang | Xuzhou Cancer Hospital |
10:21-10:30 | 10:21-10:30 |
Discussion |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
11:00-11:15 | 11:00-11:15 |
New Era of P2Y12 Inhibitor Monotherapy: Insights from the TWILIGHT Trial |
Juntang Xu | Peking University People’s hospital |
11:15-11:22 | 11:15-11:22 |
Discussion |
||
11:22-11:37 | 11:22-11:37 |
How Far Does Precise Antithrombotic Therapy Stay with Us: Insights from the TAILOR-PCI Trial |
Jian Liu | Peking University People’s hospital |
11:37-11:44 | 11:37-11:44 |
Discussion |
||
11:44-11:59 | 11:44-11:59 |
The Double-Edged Sword of Antithrombotic Therapy on Diabetes: Insight from the THEMIS Trial |
Zhenyu Liu | Peking Union Medical College Hospital |
11:59-12:06 | 11:59-12:06 |
Discussion |
||
12:06-12:21 | 12:06-12:21 |
Antithrombotic Therapy of Patients with Coronary Artery Disease and Atrial Fibrillation: Insight from the AUGUSTUS Trial |
Qi Zhang | Shanghai East Hospital, Tongji University |
12:21-12:30 | 12:21-12:30 |
Discussion |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
12:30-12:45 | 12:30-12:45 |
Real-World Experiences on Perioperative Antithrombotic Therapy in Patients undergoing PCI: Lessons from the CCC Project |
Juying Qian | Zhongshan Hospital, Fudan University |
12:45-12:52 | 12:45-12:52 |
Discussion |
||
12:52-13:07 | 12:52-13:07 |
Dual Antiplatelet Therapy after PCI: A Single-Center Data Analysis from Fuwai Hospital |
Jinqing Yuan | Fuwai Hospital Chinese Academy of Medical Sciences |
13:07-13:14 | 13:07-13:14 |
Discussion |
||
13:14-13:29 | 13:14-13:29 |
Current Status of Antiplatelet Therapy of CAD Patients in China: Insights from the OPT-CAD Study |
Yi Li | General Hospital of Northern Theater Command |
13:29-13:36 | 13:29-13:36 |
Discussion |
||
13:36-13:51 | 13:36-13:51 |
Parenteral Anticoagulation Therapy in Chinese Patients Undergoing PCI for ACS |
Chun Lin | Guangdong Provincial People's Hospital |
13:51-14:00 | 13:51-14:00 |
Discussion |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
14:00-14:15 | 14:00-14:15 |
Antithrombotic Strategies for Medically Managed ACS Patients |
Lixia Yang | The 920 Hospital |
14:15-14:30 | 14:15-14:30 |
Antithrombotic Strategies for Elderly CAD Patients |
Yumin Zhang | The Third Hospital of Changsha |
14:30-14:45 | 14:30-14:45 |
Antithrombotic Therapy for CAD Patients Complicated with Atrial Fibrillation |
Wei Guo | |
14:45-15:00 | 14:45-15:00 |
Application of NOAC in High Risk CAD Patients |
Yihong Sun | China-Japan Friendship Hospital |
15:00-15:15 | 15:00-15:15 |
Exploration on De-Escalation of Antiplatelet Therapy |
Yue Li | The 1st Affiliated Hospital of Harbin Medical University |
15:15-15:30 | 15:15-15:30 |
Short DAPT Durations after New Generation DES Implantation |
jie deng |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
16:00-16:15 | 16:00-16:15 |
Antithrombotic Strategies for ACS Patients with High Bleeding Risk |
Chunjian Li | Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University) |
16:15-16:30 | 16:15-16:30 |
Optimized Antithrombotic Therapy in ACS Patients undergoing PCI |
Xiang Xie | Department of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830011 P.R., China. |
16:30-16:45 | 16:30-16:45 |
Experience of Bivalirudin during Emergency PCI for STEMI |
Zhenyang Liang | General Hospital of Northern Theater Command |
16:45-17:00 | 16:45-17:00 |
Optimal DAPT Duration in ACS Patients after PCI |
Xubo Shi | Beijing Tongren Hospital, Capital Medical University, |
17:00-17:15 | 17:00-17:15 |
Diagnosis and Management of Thrombocytopenia in ACS Patients undergoing PCI |
Juntang Xu | Peking University People’s hospital |
17:15-17:30 | 17:15-17:30 |
Prevention and Management of GI Bleeding in ACS Patients on DAPT |
Xiaozeng Wang | General Hospital of Northern Theater Command |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
19:00-19:05 | 19:00-19:05 |
Opening
Yida Tang
Peking University Third Hospital /
Shenghua Zhou
/
Jingbo Hou
The 2nd Affiliated Hospital of Harbin Medical University
|
||
19:05-19:25 | 19:05-19:25 |
Overview of Antithrombotic Therapy for Coronary Artery Disease |
Xiaoping Ji | Qilu Hospital of Shandong University |
19:25-19:45 | 19:25-19:45 |
Development and Exploration of Antithrombotic Strategy After PCI |
Jing Li | Xuanwu Hospital Capital Medical University |
19:45-20:05 | 19:45-20:05 |
Optimized Antithrombotic Therapy in Patients with Chronic Coronary Artery Disease with High Ischemic Risk: Lessons from COMPASS Study |
Haitao Yuan | Shandong Provincial Hospital |
20:05-20:25 | 20:05-20:25 |
New Considerations of Precise Primary Prevention of Coronary Artery Disease |
Lingyun Zu | Peking University Third Hospital |
20:25-20:45 | 20:25-20:45 |
Risk Assessment and Management of Gastrointestinal Tract Damage Caused by Antiplatelet Drugs |
Peng Li | Beijing Friendship Hospital, Capital Medical University |
20:45-21:00 | 20:45-21:00 |
Discussion |